Latest news with #UniversalHealth
New Straits Times
07-07-2025
- Health
- New Straits Times
Health Ministry, IHH Healthcare ink MoU to expand free cancer treatment for 500 patients
PUTRAJAYA: The Health Ministry (MOH) and IHH Healthcare Malaysia signed their third Memorandum of Understanding (MoU) today, aimed at strengthening a strategic public-private partnership to improve access to advanced cancer treatment. Health Minister Datuk Seri Dr Dzulkefly Ahmad said the agreement will enable an additional 500 cancer patients to receive high-quality radiotherapy and radiosurgery at no cost, through services delivered by MOH oncologists and neurosurgeons via IHH's facilities. "This agreement also brings the total number of participating IHH facilities to eight hospitals, including the newly added Island Hospital in Penang, which are equipped with Gamma Knife and LINAC technologies allowing for precise, high-impact treatment, especially for tumours located in sensitive areas," he said after the MoU signing ceremony. The MoU was signed by MOH secretary-general Datuk Seri Suriani Ahmad and IHH Healthcare Malaysia chief executive officer Jean-François Naa. Dzulkefly said the collaboration, first established in 2022, has benefited 1,000 cancer patients nationwide so far. "This collaboration is a concrete step toward closing the access gap for underserved and lower-income groups. It also reflects Malaysia's broader commitment to Universal Health Coverage, where cancer care is not treated as a privilege but as a right. "We should never allow a patient's health outcome to be dictated by where they live or how much they earn," he said. Dzulkefly said from 2020 to 2024, the Malaysia National Cancer Registry recorded more than 165,000 new cancer cases, with breast, colorectal, lung, lymphoma and liver cancer being the most common. "Alarmingly, over 60 per cent of cases are detected at late stages, when treatment is more complex, costly, and less effective," he said. Meanwhile, according to a statement issued by MOH, the types of cancer treated under the MoU include brain tumours, brain metastases, head and neck cancers, as well as various other cancers such as lung, breast, colorectal and lymphoma. It said the MoU would serve as a catalyst in strengthening public-private partnerships, further supporting the ministry's efforts in combating cancer and expanding access to care and treatment for cancer patients in the country through continued cooperation between the MOH and IHH Healthcare Malaysia. "This initiative is also aligned with the National Strategic Plan for Cancer Control, which prioritises early detection, effective treatment, palliative care and broad system coordination to reduce the national cancer burden," the statement read. — BERNAMA
Barnama
07-07-2025
- Health
- Barnama
MOH, IHH Healthcare Malaysia Ink MoU To Expand Free Cancer Treatment For 500 Patients
PUTRAJAYA, July 7 (Bernama) -- The Health Ministry (MOH) and IHH Healthcare Malaysia signed their third Memorandum of Understanding (MoU) today, aimed at strengthening a strategic public-private partnership to improve access to advanced cancer treatment. Health Minister Datuk Seri Dr Dzulkefly Ahmad said the agreement will enable an additional 500 cancer patients to receive high-quality radiotherapy and radiosurgery at no cost, through services delivered by MOH oncologists and neurosurgeons via IHH's facilities. 'This agreement also brings the total number of participating IHH facilities to eight hospitals, including the newly added Island Hospital in Penang, which are equipped with Gamma Knife and LINAC technologies allowing for precise, high-impact treatment, especially for tumours located in sensitive areas,' he said after the MoU signing ceremony. The MoU was signed by MOH secretary-general Datuk Seri Suriani Ahmad and IHH Healthcare Malaysia chief executive officer Jean-François Naa. Dzulkefly said the collaboration, first established in 2022, has benefited 1,000 cancer patients nationwide so far. 'This collaboration is a concrete step toward closing the access gap for underserved and lower-income groups. It also reflects Malaysia's broader commitment to Universal Health Coverage, where cancer care is not treated as a privilege but as a right. 'We should never allow a patient's health outcome to be dictated by where they live or how much they earn,' he said. Dzulkefly said from 2020 to 2024, the Malaysia National Cancer Registry recorded more than 165,000 new cancer cases, with breast, colorectal, lung, lymphoma and liver cancer being the most common. 'Alarmingly, over 60 per cent of cases are detected at late stages, when treatment is more complex, costly, and less effective,' he said.
Business Insider
05-07-2025
- Business
- Business Insider
Leerink Partners Keeps Their Buy Rating on Universal Health (UHS)
In a report released yesterday, Whit Mayo from Leerink Partners reiterated a Buy rating on Universal Health. The company's shares closed last Thursday at $184.53. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Mayo covers the Healthcare sector, focusing on stocks such as Universal Health, UnitedHealth, and HCA Healthcare. According to TipRanks, Mayo has an average return of 2.7% and a 49.39% success rate on recommended stocks. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Universal Health with a $229.09 average price target, implying a 24.15% upside from current levels. In a report released on June 24, Barclays also maintained a Buy rating on the stock with a $257.00 price target. Based on Universal Health's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $4.1 billion and a net profit of $316.68 million. In comparison, last year the company earned a revenue of $3.84 billion and had a net profit of $261.83 million Based on the recent corporate insider activity of 51 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of UHS in relation to earlier this year. Most recently, in May 2025, Maria Singer Ruderman, a Director at UHS sold 1,097.00 shares for a total of $210,042.59.
GMA Network
05-06-2025
- Health
- GMA Network
DOH: BUCAS centers have served almost 860,000 patients as of June 2025
DOH opens a Bagong Urgent Care and Ambulatory Services (BUCAS) Center in Rizal, Nueva Ecija on October 16, 2024. Photo: Department of Health The Bagong Urgent Care Ambulatory Services (BUCAS) Centers of the Department of Health (DOH) have assisted nearly 860,000 patients as of June 2025, Health Secretary Teodoro Herbosa said. In a Palace press briefing on Thursday, Herbosa said that all 51 BUCAS centers nationwide continue to serve Filipinos by offering additional health services to avoid longer lines at DOH hospitals. 'Patunay po ito na mas mabilis na naihatid ng ating mga kababayan ang mga serbisyong medikal dahil noong March 2024 lang po tayo nagsimula… Ngayon, 26 na po ang operational sa Luzon, habang 8 sa Visayas at 17 sa Mindanao,' he shared. (This proves that medical services are being immediately provided to Filipinos, since we only started in March 2024… Now, there are 26 operational in Luzon, while 8 are in Visayas and 17 are in Mindanao.) The first BUCAS Center was opened in Sto. Tomas, Pampanga in March 6, 2024, in accordance with the Regional Specialty Centers Act to 'institutionalize the establishment of specialty and healthcare centers across the country.' 'May libreng gamot din po kaming binibigay sa BUCAS kagaya ng maintenance para sa high blood at diabetes. Mayroon din po kaming prenatal check-up para sa mga buntis, libreng bakuna at anti-rabies shot para sa mga nakagat ng hayop,' Herbosa said. (There is also free medicine being given in BUCAS, such as maintenance for high blood and diabetes. There are also prenatal check-ups for pregnant women, free vaccinations and anti-rabies shots for those bitten by animals.) 'Ang BUCAS ay bahagi ng layunin ng DOH na mas maramdaman ng mga kababayan natin ang Universal Health Care dahil ang bilin po ng Presidente ay patas na access at komprehensibong serbisyong pangkalusugan ang nabibigay sa iba't ibang parte ng bansa,' he added. (BUCAS is part of the DOH's advocacy to further bring Universal Health Care to Filipinos because the President has ordered equal access and comprehensive health services to be given to different parts of the country.) — BM, GMA Integrated News
Business Insider
05-06-2025
- Business
- Business Insider
Leerink Partners Sticks to Its Buy Rating for Universal Health (UHS)
In a report released yesterday, Whit Mayo from Leerink Partners maintained a Buy rating on Universal Health (UHS – Research Report), with a price target of $252.00. The company's shares closed yesterday at $188.65. Confident Investing Starts Here: Mayo covers the Healthcare sector, focusing on stocks such as Humana, Pediatrix Medical Group, and Tenet Healthcare. According to TipRanks, Mayo has an average return of 2.9% and a 49.75% success rate on recommended stocks. In addition to Leerink Partners, Universal Health also received a Buy from Wells Fargo's Stephen Baxter in a report issued on May 29. However, yesterday, Morgan Stanley maintained a Hold rating on Universal Health (NYSE: UHS). Based on Universal Health's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $4.1 billion and a net profit of $316.68 million. In comparison, last year the company earned a revenue of $3.84 billion and had a net profit of $261.83 million Based on the recent corporate insider activity of 51 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of UHS in relation to earlier this year. Last month, Maria Singer Ruderman, a Director at UHS sold 1,097.00 shares for a total of $210,042.59.
